ZIM
ATRC icon

Zacks Investment Management’s AtriCure ATRC Stock Holding History

Zacks Investment Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-8,773
Closed -$610K – 609
2021
Q3 		$610K Sell
8,773
-5,152
-37% -$396K 0.01% 432
2021
Q2 		$1.1M Buy
+13,925
New +$1.01M 0.02% 354

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Zacks Investment Management's ATRC Position: Q4 2021 in Review

Zacks Investment Management sold out of AtriCure (ATRC) in Q4 2021, closing a stake of 8,773 shares — an estimated $610K sold.

Zacks Investment Management first reported a position in ATRC in Q2 2021 and held it in 2 quarters. The position peaked at $1.1M in Q2 2021. 217 funds tracked by Wall St. Rank hold ATRC as of Q4 2021.

  • Zacks Investment Management reported no remaining AtriCure position as of Q4 2021 after selling out during the quarter.
  • Zacks Investment Management sold 8,773 AtriCure shares in Q4 2021, an estimated $610K.
  • Zacks Investment Management first reported a position in AtriCure in Q2 2021 and held it in 2 quarters.
  • Zacks Investment Management's AtriCure position peaked at $1.1M in Q2 2021.
  • 217 funds tracked by Wall St. Rank held AtriCure as of Q4 2021.

Based on Zacks Investment Management's 13F filing for Q4 2021, filed 15 Feb 2022.